6:54 PM
 | 
Jun 21, 2005
 |  BC Extra  |  Company News

Shire returns Adept rights

Shire (LSE:SHP; SHPGY) will return European marketing rights to Adept icodextrin to ML Labs (LSE:MLB) effective Dec. 30. The drug is approved in...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >